Cargando…
Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia
OBJECTIVE: To investigate the relationship between serum high mobility group box-1 protein (HMGB-1) levels and prognosis in patients with community-acquired pneumonia (CAP). METHODS: This prospective study included 35 patients who attended our hospital from January 2016 to December 2016. Pneumonia s...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421397/ https://www.ncbi.nlm.nih.gov/pubmed/30732500 http://dx.doi.org/10.1177/0300060518819381 |
_version_ | 1783404232494284800 |
---|---|
author | Lu, Huasong Zeng, Nengyong Chen, Quanfang Wu, Yanbin Cai, Shuanqi Li, Gengshen Li, Fei Kong, Jinliang |
author_facet | Lu, Huasong Zeng, Nengyong Chen, Quanfang Wu, Yanbin Cai, Shuanqi Li, Gengshen Li, Fei Kong, Jinliang |
author_sort | Lu, Huasong |
collection | PubMed |
description | OBJECTIVE: To investigate the relationship between serum high mobility group box-1 protein (HMGB-1) levels and prognosis in patients with community-acquired pneumonia (CAP). METHODS: This prospective study included 35 patients who attended our hospital from January 2016 to December 2016. Pneumonia severity was defined by pneumonia severity index (PSI). Serum levels of C-reactive protein (CRP), cortisol, and HMGB-1 were analyzed in relation to disease severity and clinical outcome. RESULTS: High HMGB-1 levels were associated with high cortisol levels. High HMGB-1 and high cortisol were both significantly associated with high white blood cell count and high serum CRP, compared with low HMGB-1 and low cortisol, respectively. PSI score and 30-day mortality were also significantly higher in patients with high HMGB-1 or high cortisol levels compared with patients with low HMGB-1 or cortisol levels, respectively. CRP, cortisol, and HMGB-1 levels were all significantly higher in patients who died compared with survivors. CONCLUSION: HMGB-1 was associated with clinical outcomes and was an independent risk factor for 30-day mortality in patients with CAP. Serum HMGB-1 levels were also positively correlated with serum levels of cortisol. These results demonstrate a role for HMGB-1 in CAP, and suggest possible new therapeutic targets for patients with CAP. |
format | Online Article Text |
id | pubmed-6421397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-64213972019-03-22 Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia Lu, Huasong Zeng, Nengyong Chen, Quanfang Wu, Yanbin Cai, Shuanqi Li, Gengshen Li, Fei Kong, Jinliang J Int Med Res Clinical Research Reports OBJECTIVE: To investigate the relationship between serum high mobility group box-1 protein (HMGB-1) levels and prognosis in patients with community-acquired pneumonia (CAP). METHODS: This prospective study included 35 patients who attended our hospital from January 2016 to December 2016. Pneumonia severity was defined by pneumonia severity index (PSI). Serum levels of C-reactive protein (CRP), cortisol, and HMGB-1 were analyzed in relation to disease severity and clinical outcome. RESULTS: High HMGB-1 levels were associated with high cortisol levels. High HMGB-1 and high cortisol were both significantly associated with high white blood cell count and high serum CRP, compared with low HMGB-1 and low cortisol, respectively. PSI score and 30-day mortality were also significantly higher in patients with high HMGB-1 or high cortisol levels compared with patients with low HMGB-1 or cortisol levels, respectively. CRP, cortisol, and HMGB-1 levels were all significantly higher in patients who died compared with survivors. CONCLUSION: HMGB-1 was associated with clinical outcomes and was an independent risk factor for 30-day mortality in patients with CAP. Serum HMGB-1 levels were also positively correlated with serum levels of cortisol. These results demonstrate a role for HMGB-1 in CAP, and suggest possible new therapeutic targets for patients with CAP. SAGE Publications 2019-02-07 2019-03 /pmc/articles/PMC6421397/ /pubmed/30732500 http://dx.doi.org/10.1177/0300060518819381 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Clinical Research Reports Lu, Huasong Zeng, Nengyong Chen, Quanfang Wu, Yanbin Cai, Shuanqi Li, Gengshen Li, Fei Kong, Jinliang Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia |
title | Clinical prognostic significance of serum high mobility group box-1
protein in patients with community-acquired pneumonia |
title_full | Clinical prognostic significance of serum high mobility group box-1
protein in patients with community-acquired pneumonia |
title_fullStr | Clinical prognostic significance of serum high mobility group box-1
protein in patients with community-acquired pneumonia |
title_full_unstemmed | Clinical prognostic significance of serum high mobility group box-1
protein in patients with community-acquired pneumonia |
title_short | Clinical prognostic significance of serum high mobility group box-1
protein in patients with community-acquired pneumonia |
title_sort | clinical prognostic significance of serum high mobility group box-1
protein in patients with community-acquired pneumonia |
topic | Clinical Research Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421397/ https://www.ncbi.nlm.nih.gov/pubmed/30732500 http://dx.doi.org/10.1177/0300060518819381 |
work_keys_str_mv | AT luhuasong clinicalprognosticsignificanceofserumhighmobilitygroupbox1proteininpatientswithcommunityacquiredpneumonia AT zengnengyong clinicalprognosticsignificanceofserumhighmobilitygroupbox1proteininpatientswithcommunityacquiredpneumonia AT chenquanfang clinicalprognosticsignificanceofserumhighmobilitygroupbox1proteininpatientswithcommunityacquiredpneumonia AT wuyanbin clinicalprognosticsignificanceofserumhighmobilitygroupbox1proteininpatientswithcommunityacquiredpneumonia AT caishuanqi clinicalprognosticsignificanceofserumhighmobilitygroupbox1proteininpatientswithcommunityacquiredpneumonia AT ligengshen clinicalprognosticsignificanceofserumhighmobilitygroupbox1proteininpatientswithcommunityacquiredpneumonia AT lifei clinicalprognosticsignificanceofserumhighmobilitygroupbox1proteininpatientswithcommunityacquiredpneumonia AT kongjinliang clinicalprognosticsignificanceofserumhighmobilitygroupbox1proteininpatientswithcommunityacquiredpneumonia |